Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230112 · ClinicalTrials.gov registry record
The Role of ITGAM in Systemic Lupus Erythematosus
A clinical trial of Systemic Lupus Erythematosus, sponsored by Northwell Health.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT01230112 is a study of Systemic Lupus Erythematosus that has completed, run by Northwell Health. The registered enrollment target is 40 participants, below the 380-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01230112, a study of Systemic Lupus Erythematosus, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Study to examine the role of ITGAM molecule in normal control subjects with known genetic variation in the ITGAM gene.
Conditions Studied
Study Locations (1)
New York
- Feinstein Institute for Medical Research - Manhasset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01230112
The ClinicalTrials.gov registry entry for NCT01230112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (89% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 0 interventions.
NCT01230112 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01230112 about?
NCT01230112 is a clinical study titled "The Role of ITGAM in Systemic Lupus Erythematosus". Study to examine the role of ITGAM molecule in normal control subjects with known genetic variation in the ITGAM gene.
What is the current status of trial NCT01230112?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-12. Estimated completion is 2012-04.
What conditions does trial NCT01230112 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus.
Who is sponsoring clinical trial NCT01230112?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01230112 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
RECRUITING · Phase 3
-
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
RECRUITING · Phase 1
-
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
RECRUITING
-
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.